Skip to main content
Premium Trial:

Request an Annual Quote

Michael Forrest Named to AlphaGene's Board

Premium

WOBURN, Mass.--Michael Forrest, president and CEO of the drug discovery company Cellegy Pharmaceuticals, has been ap pointed to the board of directors of AlphaGene Inc., a bioinformatics and medical genomics company here.

Forrest previously served as president and CEO of Mercator Genetics, a genomics company focused on positional cloning, and of Transkaryotic Therapies Inc. He has also worked for American Cyanamid and Pfizer.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.